ImmunoFrontier’s bussiness goals
ImmunoFrontier’s bussiness goals are the following four:
Development of “cancer protein vaccines” employing cancer-specific proteins as antigens and Cholesteryl Pullulan (CHP) as the antigen delivery system.
Creation of next generation protein drugs using CHP delivery system.
R&D of “cancer DNA vaccines”, which are next generation cancer vaccines.
R&D of the modulators of regulatory T cell functions for the treatment of intractable immune diseases.